Advanced glycation end products and sorbitol in blood from differently compensated diabetic dogs.
Canine diabetes mellitus (DM) is a common metabolic disorder with long term complications, most of which are caused by glycosylation of structural proteins, decreases in antioxidant concentrations, altered osmotic balance and hypoxia due to impaired oxygen transport. Previous studies have demonstrated that under hyperglycemic conditions canine erythrocytes undergo swelling, probably due to activation of the polyol pathway. The present work aimed to assess the plasma concentration of advanced glycation end (AGE) products, stable Amadori-products generated by non-enzymatic glycosylation of proteins and the intracellular concentration of sorbitol, produced by the activation of polyol pathway in 34 blood samples from diabetic dogs and in 14 controls. AGE products were significantly higher (p<0.01) in plasma from diabetic dogs compared with control animals. The sorbitol concentration in erythrocytes was also significantly higher in diabetic dogs and, in particular, in poorly compensated animals and in dogs with ketonuria. In five cases that were analysed before and after clinical improvement, sorbitol concentration was found to correlate with improvement. These results suggest that non-specific glycosylation is increased and that the polyol pathway is activated in diabetic dogs in a manner that is proportionate to the severity of disease. Moreover, the concentration of AGE products and sorbitol may be useful for monitoring the onset of diabetic complications and assessing the most appropriate therapeutic approaches for management of canine DM.
Comazzi
S
S
Department of Veterinary Pathology, Hygiene and Health, University of Milan, Italy. stefano.comazzi@unimi.it
Bertazzolo
W
W
Bonfanti
U
U
Spagnolo
V
V
Sartorelli
P
P
D000818:Animals; D003920:Diabetes Mellitus / Q000097:blood / Q000662:veterinary*; D004283:Dog Diseases / Q000097:blood*; D004285:Dogs; D005260:Female; D017127:Glycation End Products, Advanced / Q000097:blood*; D006943:Hyperglycemia / Q000097:blood / Q000662:veterinary; D008297:Male; D015203:Reproducibility of Results; D013012:Sorbitol / Q000097:blood*
D017127:Glycation End Products, Advanced; D013012:Sorbitol